Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake
David L. Silver, Nan Wang, Alan R. Tall
David L. Silver, Nan Wang, Alan R. Tall
View: Text | PDF
Article

Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake

  • Text
  • PDF
Abstract

Levels of plasma HDL are determined in part by catabolism in the liver. However, it is unclear how the hepatic catabolism of holo-HDL is regulated or mediated. Recently, we found that ob/ob mice have defective liver catabolism of HDL apoproteins in vivo that can be reversed by low-dose leptin treatment. Here we examined HDL catabolism and trafficking at the cellular level using isolated hepatocytes. We demonstrate that ob/ob hepatocytes have reduced binding, association, degradation, and resecretion of HDL apoproteins and 50% less selective lipid uptake relative to wild-type hepatocytes. In addition, HDL apoproteins were found to colocalize with transferrin in the general endosomal recycling compartment (ERC) in wild-type hepatocytes. However, the localization to the ERC was markedly reduced in ob/ob hepatocytes. Filipin staining of cellular cholesterol revealed decreased cholesterol in the ERC in ob/ob hepatocytes. Defects in HDL cell association and cholesterol distribution were reversed by leptin administration. The findings show a major defect in HDL uptake and recycling in ob/ob hepatocytes and suggest that HDL recycling through the ERC plays a role in the determination of plasma HDL protein and cholesterol levels.

Authors

David L. Silver, Nan Wang, Alan R. Tall

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Leptin restores the defect in HDL uptake by ob/ob primary hepatocytes an...
Leptin restores the defect in HDL uptake by ob/ob primary hepatocytes and the altered localization pattern of HDL apoproteins in primary ob/ob hepatocytes. (a) ob/ob mice were injected twice daily with 1 μg/g body weight leptin for the times indicated. Control ob/ob mice (0 hour time point) were injected twice daily with saline and pair-fed to the leptin-treated mice. After treatments, hepatocytes were isolated and incubated with either apoE-free human 125I-HDL or Alexa-HDL (see Figure 6) at 37°C for 1 hour. Cells were then washed, and total cell radioactivity was counted. All experiments used 5 μg of HDL and were performed a total of 2–3 times in triplicate with similar results. Results were reported as mean nanogram of HDL per milligram of cell protein per hour ± SD, after subtraction of background counts measured in the presence of 100-fold excess unlabeled HDL (*0 and 24 hours versus 48 and 72 hours; P < 0.005). (b) Primary hepatocytes from a were incubated with Alexa-HDL at 37°C for 1 hour. Cells were then washed, fixed, and examined using confocal microscopy. Apoproteins in hepatocytes from leptin-treated ob/ob mice were localized in a similar pattern as seen in wild-type mice, i.e., juxtanuclear location. All experiments used 5 μg of HDL and were performed a total of 3 times with similar results.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts